{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Abstract\n",
    "\n",
    "<font color='blue' size='small'>\n",
    "    Verbatim abstract text in blue follows each analysis.<br>\n",
    "    </font>\n",
    "<br>\n",
    "SUBMITTED Version of ICPE 2020 KY Survey Early Prescribers (2339 characters of 2350 limit)<br>\n",
    "<br>\n",
    "\n",
    "---"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Do Early Prescribers Of New Drugs Have Different Risk Management Practices?**<br>\n",
    "Submitted ICPE 2020 abstract #4157<br>\n",
    "<br>\n",
    "Dasgupta N, Brown JR, Freeman P, Nocera M, Slavova S<br>\n",
    "<br>\n",
    "## Background\n",
    "Uptake of new technology occurs first in \"early adopters.\" We hypothesized that early prescribers of new medicines could likewise be identified, possibly influencing interpretation of early post-market assessments.\n",
    "<br>\n",
    "## Objectives\n",
    "Conduct a statewide prescriber survey to evaluate if self-described early prescribers have differences in risk management practices compared to later prescribers.\n",
    "<br>\n",
    "## Methods\n",
    "Planned hypothesis generating analysis of a larger survey on opioid prescribing, fielded by state licensing authority in Nov 2019.\n",
    "<br>**Setting**: All DEA-registered Kentucky (US) physicians.\n",
    "<br>**Exposure**: Self-reported affirmation of any of 3 statements: I prescribe new medications before others; I enjoy the variety of prescribing new medicines; I like to share with colleagues about new medicines I've prescribed. (Other options: I feel more comfortable using familiar medications, etc.). <br>**Outcome**: Physician characteristics, opioid prescribing.\n",
    "<br>**Analysis**: Descriptive univariable/bivariable stats\n",
    "<br>\n",
    "## Results\n",
    "Emails were delivered to 7631 physicians, with 651 respondents (8.5% - similar to other unincentivized physician surveys). After limiting to controlled substance prescribers and removing incommpletes, the analysis sample was n=349, with 83 (24%) early prescribers. Early adopters were disproportionately in early or late career (less than 15 or 35+ practice-years). The male:female ratio was 2:1 among respondents, but proportionately more females (26%) than males (19%) were early adopters. There were no differences in patient load, practice setting, or medical specialty except emergency medicine and general surgery were less likely; and oncology and OB/GYN were more likely to be early adopters.<br>\n",
    "\n",
    "Early prescribers were more likely to use opioid risk stratification tools (OR 1.5; 0.85, 2.7). Abuse deterrent formulation (ADF) opioid prescribing was similar (OR 1.1; 0.65, 1.8). However, early adopters were more likely (OR 1.4; 0.73, 2.6) to prescribe newer non-OxyContin ADFs, with 93% endorsing \"innovative nature of abuse-deterrence mechanisms\" as a consideration. They supported legislation mandating insurance coverage for ADFs (OR 3.5; 1.6, 8.9), and more strongly endorsed technical solutions like electronic prescription monitoring programs and urine drug screens, while opposing prescribing limits.\n",
    "<br>\n",
    "## Conclusions\n",
    "In addition to prescribing newer medications, early adopters may differ in other healthcare delivery aspects that may impact care. The survey is being replicated in other states. Quantitative assessments will follow. Studies with historical controls may want to consider impacts of early adopters."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "---\n",
    "# Data preparation\n",
    "## Import data, create ADF variables"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Notebook generated on 12 Feb 2020 at 11:54:31 ET\n",
      "\n",
      "/Users/nabarun/Dropbox/Projects/P1 Surveys\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "(MethodologicalAdvanc_DATA_NOHDRS_2020-01-28_1653.csv)\n",
      "\n",
      "\n",
      "(MethodologicalAdvanc_DATA_NOHDRS_2020-01-28_1510.csv)\n",
      "\n",
      "  default  0 x 0\n",
      "  docs     686 x 105; MethodologicalAdvanc_DATA_NOHDRS_2020-01-28_1510.csv\n",
      "  pharm    827 x 107; MethodologicalAdvanc_DATA_NOHDRS_2020-01-28_1653.csv\n",
      "\n",
      "\n",
      "Exclude non-controlled substance prescribers and incomplete surveys:\n",
      "\n",
      "(206 observations deleted)\n",
      "\n",
      "\n",
      "(46 real changes made)\n",
      "(37 real changes made)\n",
      "(54 real changes made)\n",
      "(44 real changes made)\n",
      "(176 real changes made)\n",
      "\n",
      "\n",
      "(187 real changes made)\n",
      "\n",
      "\n",
      "\n",
      "    Any ADF |\n",
      "prescribing |      Freq.     Percent        Cum.\n",
      "------------+-----------------------------------\n",
      "          0 |        293       61.04       61.04\n",
      "          1 |        187       38.96      100.00\n",
      "------------+-----------------------------------\n",
      "      Total |        480      100.00\n",
      "\n",
      "\n",
      "(71 real changes made)\n",
      "\n",
      "\n",
      "\n",
      "        Any |\n",
      "non-OxyCont |\n",
      "     in ADF |\n",
      "prescribing |      Freq.     Percent        Cum.\n",
      "------------+-----------------------------------\n",
      "          0 |        409       85.21       85.21\n",
      "          1 |         71       14.79      100.00\n",
      "------------+-----------------------------------\n",
      "      Total |        480      100.00\n",
      "\n",
      "\n",
      "(68 real changes made)\n",
      "\n",
      "(365 real changes made, 365 to missing)\n"
     ]
    }
   ],
   "source": [
    "display \"Notebook generated on $S_DATE at $S_TIME ET\"\n",
    "\n",
    "cd \"/Users/nabarun/Dropbox/Projects/P1 Surveys\"\n",
    "clear all\n",
    "set more off\n",
    "\n",
    "frame create pharm\n",
    "    frame pharm: use pharmacistky\n",
    "frame create docs\n",
    "    frame docs: use prescriberky\n",
    "frame dir\n",
    "frame change docs\n",
    "\n",
    "di \"Exclude non-controlled substance prescribers and incomplete surveys:\"\n",
    "keep if contr_sub==1\n",
    "    * n=206 deleted\n",
    "\n",
    "// Create composite variables for ADF prescribing\n",
    "\n",
    "local adfs \"embeda hysinglaer morphabonder xtampzaer oxycontin\"\n",
    "foreach i of local adfs {\n",
    "    gen any`i'=0\n",
    "        replace any`i'=1 if inlist(`i',2,3,4,5)\n",
    "            order any`i', a(`i')\n",
    "                *tab any`i'\n",
    "                    la var any`i' \"Any reported prescribing of `i'\"\n",
    "}\n",
    "\n",
    "gen anyadf=0\n",
    "    replace anyadf=1 if anyembeda==1 | anyhysinglaer==1 | anymorphabond==1 | anyxtampzaer==1 | anyoxycontin==1\n",
    "        la var anyadf \"Any ADF prescribing\"\n",
    "            tab anyadf\n",
    "\n",
    "gen anynotocadf=0\n",
    "    replace anynotocadf=1 if anyembeda==1 | anyhysinglaer==1 | anymorphabond==1 | anyxtampzaer==1\n",
    "        la var anynotocadf \"Any non-OxyContin ADF prescribing\"\n",
    "            tab anynotocadf\n",
    "            \n",
    "// Recode into innovation influence as dichotmous\n",
    "gen innovinfluence = 0\n",
    "    replace innovinfluence = 1 if inlist(innovate,3,4)\n",
    "        replace innovinfluence=. if innovate==."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "## Early adopter distributions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "note: label truncated to 80 characters\n",
      "\n",
      "\n",
      "\n",
      "    Usually |\n",
      "  prescribe |\n",
      "        new |\n",
      "medications |\n",
      "     before |\n",
      "  others do |      Freq.     Percent        Cum.\n",
      "------------+-----------------------------------\n",
      "  Unchecked |        461       96.04       96.04\n",
      "    Checked |         19        3.96      100.00\n",
      "------------+-----------------------------------\n",
      "      Total |        480      100.00\n",
      "\n",
      "     Prefer |\n",
      "medications |\n",
      " which have |\n",
      "worked well |\n",
      "        for |\n",
      "patients in |\n",
      "   the past |      Freq.     Percent        Cum.\n",
      "------------+-----------------------------------\n",
      "  Unchecked |        315       65.62       65.62\n",
      "    Checked |        165       34.38      100.00\n",
      "------------+-----------------------------------\n",
      "      Total |        480      100.00\n",
      "\n",
      " Like being |\n",
      "    able to |\n",
      " share with |\n",
      " colleagues |\n",
      "  about new |\n",
      "medications |\n",
      "       I've |\n",
      " prescribed |      Freq.     Percent        Cum.\n",
      "------------+-----------------------------------\n",
      "  Unchecked |        444       92.50       92.50\n",
      "    Checked |         36        7.50      100.00\n",
      "------------+-----------------------------------\n",
      "      Total |        480      100.00\n",
      "\n",
      "   Like the |\n",
      " variety of |\n",
      "prescribing |\n",
      "        new |\n",
      "medications |      Freq.     Percent        Cum.\n",
      "------------+-----------------------------------\n",
      "  Unchecked |        434       90.42       90.42\n",
      "    Checked |         46        9.58      100.00\n",
      "------------+-----------------------------------\n",
      "      Total |        480      100.00\n",
      "\n",
      "  Feel more |\n",
      "comfortable |\n",
      "      using |\n",
      "   familiar |\n",
      "medications |      Freq.     Percent        Cum.\n",
      "------------+-----------------------------------\n",
      "  Unchecked |        276       57.50       57.50\n",
      "    Checked |        204       42.50      100.00\n",
      "------------+-----------------------------------\n",
      "      Total |        480      100.00\n",
      "\n",
      "  Prefer to |\n",
      " wait until |\n",
      "     I hear |\n",
      "      about |\n",
      "colleagues' |\n",
      "experiences |\n",
      "       with |\n",
      "prescribing |\n",
      "      new m |      Freq.     Percent        Cum.\n",
      "------------+-----------------------------------\n",
      "  Unchecked |        328       68.33       68.33\n",
      "    Checked |        152       31.67      100.00\n",
      "------------+-----------------------------------\n",
      "      Total |        480      100.00\n",
      "\n",
      "\n",
      "\n",
      "     +-----------------------------------------------------------------------------------+\n",
      "     | early_adopt_other                                                                 |\n",
      "     |-----------------------------------------------------------------------------------|\n",
      "  3. | Rarely recommend or prescribe new medications due to cost and coverage issues.    |\n",
      " 21. | mix between EBM and looking for 'outside of the box' approach                     |\n",
      " 43. | Wait at least 6 months before prescribing                                         |\n",
      " 65. | Most of the time Medications with abuse deterrent are not covered by insurance    |\n",
      " 69. | research the medications, look past the pharma marketing material before making.. |\n",
      "     |-----------------------------------------------------------------------------------|\n",
      " 84. | I'm a hospitalsit.                                                                |\n",
      " 89. | Be able to see some post- marketing literature                                    |\n",
      "103. | Pay for what's covered under insurance more than happy to try newer options if .. |\n",
      "107. | more intensive absolutely blinded non pharmaceutical indiustry sponsopred multi.. |\n",
      "131. | case by case basis-new doesn't necessarily mean better/improved.                  |\n",
      "     |-----------------------------------------------------------------------------------|\n",
      "163. | Look for evidence                                                                 |\n",
      "176. | Study before prescribing                                                          |\n",
      "307. | expense; don't rx opiates to anyone suspected of misuse or abuse or diversion.    |\n",
      "308. | Wait to see clinical use/stats/studies once product is on the market for severa.. |\n",
      "394. | many of my elderly and disabled patients are burdened by medication costs and p.. |\n",
      "     |-----------------------------------------------------------------------------------|\n",
      "401. | formulary is an issue and cost to patients as well would deter my prescribing     |\n",
      "412. | dont prescribe that often                                                         |\n",
      "413. | Generally, I am restricted by the cost of the new medications and the insurance.. |\n",
      "416. | It is hard to successfully prescribe new medications in this rea unless insuran.. |\n",
      "444. | patient Population limits prescribing new medications                             |\n",
      "     |-----------------------------------------------------------------------------------|\n",
      "471. | prescribe new meds in key needs, but wait with overlap or non essential meds .... |\n",
      "     +-----------------------------------------------------------------------------------+\n"
     ]
    }
   ],
   "source": [
    "la var early_adopt___1 \"Usually prescribe new medications before others do\"\n",
    "la var early_adopt___2 \"Prefer medications which have worked well for patients in the past\"\n",
    "la var early_adopt___3 \"Like being able to share with colleagues about new medications I've prescribed\"\n",
    "la var early_adopt___4 \"Like the variety of prescribing new medications\"\n",
    "la var early_adopt___5 \"Feel more comfortable using familiar medications\"\n",
    "la var early_adopt___6 \"Prefer to wait until I hear about colleagues' experiences with prescribing new medications\"\n",
    "la var early_adopt___7 \"Other\"\n",
    "\n",
    "foreach var of varlist early_adopt___1-early_adopt___6 {\n",
    "tab `var',\n",
    "}\n",
    "set linesize 90\n",
    "list early_adopt_other if early_adopt_other!=\"\""
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Define early prescribers\n",
    "Self-reported affirmative response to any of 3 statements:<br>\n",
    "`early_adopt___1`   prescribing new medications before others<br>\n",
    "`early_adopt___3`   enjoying variety of prescribing new medicines<br>\n",
    "`early_adopt___4`   liking to share with colleagues about new medicines"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\n",
      "(19 real changes made)\n",
      "\n",
      "\n",
      "Self-identi |\n",
      " fied early |\n",
      "   adopters |      Freq.     Percent        Cum.\n",
      "------------+-----------------------------------\n",
      "          0 |        461       96.04       96.04\n",
      "          1 |         19        3.96      100.00\n",
      "------------+-----------------------------------\n",
      "      Total |        480      100.00\n",
      "\n",
      "\n",
      "\n",
      "(83 real changes made)\n",
      "\n",
      "\n",
      "     Enjoys |\n",
      "      novel |\n",
      "prescribing |      Freq.     Percent        Cum.\n",
      "------------+-----------------------------------\n",
      "          0 |        397       82.71       82.71\n",
      "          1 |         83       17.29      100.00\n",
      "------------+-----------------------------------\n",
      "      Total |        480      100.00\n"
     ]
    }
   ],
   "source": [
    "// Create variables for early adopters\n",
    "gen earliest=0\n",
    "    la var earliest \"Self-identified early adopters\"\n",
    "        replace earliest = 1 if early_adopt___1==1\n",
    "            tab earliest\n",
    "\n",
    "gen early=0\n",
    "    la var early \"Enjoys novel prescribing\"\n",
    "        replace early = 1 if early_adopt___1==1 | early_adopt___3==1 | early_adopt___4==1\n",
    "            tab early"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Exclude incomplete surveys\n",
    "Keep if survey is eventually incomplete but respondent had self-identified as an early prescriber or not."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Exclude incomplete surveys while retaining early prescribers (see Section 5 for rationale)\n",
      "> :\n",
      "\n",
      "(131 observations deleted)\n",
      "\n",
      "\n",
      "Self-identi |\n",
      " fied early |\n",
      "   adopters |      Freq.     Percent        Cum.\n",
      "------------+-----------------------------------\n",
      "          0 |        330       94.56       94.56\n",
      "          1 |         19        5.44      100.00\n",
      "------------+-----------------------------------\n",
      "      Total |        349      100.00\n",
      "\n",
      "\n",
      "     Enjoys |\n",
      "      novel |\n",
      "prescribing |      Freq.     Percent        Cum.\n",
      "------------+-----------------------------------\n",
      "          0 |        266       76.22       76.22\n",
      "          1 |         83       23.78      100.00\n",
      "------------+-----------------------------------\n",
      "      Total |        349      100.00\n"
     ]
    }
   ],
   "source": [
    "di \"Exclude incomplete surveys while retaining early prescribers (see Section 5 for rationale):\"\n",
    "keep if physician_survey_complete==2 | early==1\n",
    "    * n=131 should be deleted\n",
    "\n",
    "tab earliest\n",
    "tab early"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "# Physician Characteristics\n",
    "## Gender"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "                      | Usually prescribe new\n",
      "                      |  medications before\n",
      "                      |       others do\n",
      " What is your gender? | Unchecked    Checked |     Total\n",
      "----------------------+----------------------+----------\n",
      "                 Male |       207         14 |       221 \n",
      "                      |     64.89      77.78 |     65.58 \n",
      "----------------------+----------------------+----------\n",
      "               Female |       107          4 |       111 \n",
      "                      |     33.54      22.22 |     32.94 \n",
      "----------------------+----------------------+----------\n",
      " Prefer not to answer |         5          0 |         5 \n",
      "                      |      1.57       0.00 |      1.48 \n",
      "----------------------+----------------------+----------\n",
      "                Total |       319         18 |       337 \n",
      "                      |    100.00     100.00 |    100.00 \n",
      "\n",
      "\n",
      "                      |  Like being able to\n",
      "                      | share with colleagues\n",
      "                      | about new medications\n",
      "                      |    I've prescribed\n",
      " What is your gender? | Unchecked    Checked |     Total\n",
      "----------------------+----------------------+----------\n",
      "                 Male |       205         16 |       221 \n",
      "                      |     66.34      57.14 |     65.58 \n",
      "----------------------+----------------------+----------\n",
      "               Female |        99         12 |       111 \n",
      "                      |     32.04      42.86 |     32.94 \n",
      "----------------------+----------------------+----------\n",
      " Prefer not to answer |         5          0 |         5 \n",
      "                      |      1.62       0.00 |      1.48 \n",
      "----------------------+----------------------+----------\n",
      "                Total |       309         28 |       337 \n",
      "                      |    100.00     100.00 |    100.00 \n",
      "\n",
      "\n",
      "                      |  Like the variety of\n",
      "                      |    prescribing new\n",
      "                      |      medications\n",
      " What is your gender? | Unchecked    Checked |     Total\n",
      "----------------------+----------------------+----------\n",
      "                 Male |       196         25 |       221 \n",
      "                      |     66.44      59.52 |     65.58 \n",
      "----------------------+----------------------+----------\n",
      "               Female |        94         17 |       111 \n",
      "                      |     31.86      40.48 |     32.94 \n",
      "----------------------+----------------------+----------\n",
      " Prefer not to answer |         5          0 |         5 \n",
      "                      |      1.69       0.00 |      1.48 \n",
      "----------------------+----------------------+----------\n",
      "                Total |       295         42 |       337 \n",
      "                      |    100.00     100.00 |    100.00 \n",
      "\n",
      "\n",
      "                      | Self-identified early\n",
      "                      |       adopters\n",
      " What is your gender? |         0          1 |     Total\n",
      "----------------------+----------------------+----------\n",
      "                 Male |       207         14 |       221 \n",
      "                      |     64.89      77.78 |     65.58 \n",
      "----------------------+----------------------+----------\n",
      "               Female |       107          4 |       111 \n",
      "                      |     33.54      22.22 |     32.94 \n",
      "----------------------+----------------------+----------\n",
      " Prefer not to answer |         5          0 |         5 \n",
      "                      |      1.57       0.00 |      1.48 \n",
      "----------------------+----------------------+----------\n",
      "                Total |       319         18 |       337 \n",
      "                      |    100.00     100.00 |    100.00 \n",
      "\n",
      "\n",
      "                      |     Enjoys novel\n",
      "                      |      prescribing\n",
      " What is your gender? |         0          1 |     Total\n",
      "----------------------+----------------------+----------\n",
      "                 Male |       178         43 |       221 \n",
      "                      |     67.17      59.72 |     65.58 \n",
      "----------------------+----------------------+----------\n",
      "               Female |        82         29 |       111 \n",
      "                      |     30.94      40.28 |     32.94 \n",
      "----------------------+----------------------+----------\n",
      " Prefer not to answer |         5          0 |         5 \n",
      "                      |      1.89       0.00 |      1.48 \n",
      "----------------------+----------------------+----------\n",
      "                Total |       265         72 |       337 \n",
      "                      |    100.00     100.00 |    100.00 \n",
      "\n",
      "\n",
      "                      |     Enjoys novel\n",
      "                      |      prescribing\n",
      " What is your gender? |         0          1 |     Total\n",
      "----------------------+----------------------+----------\n",
      "                 Male |       178         43 |       221 \n",
      "                      |     80.54      19.46 |    100.00 \n",
      "----------------------+----------------------+----------\n",
      "               Female |        82         29 |       111 \n",
      "                      |     73.87      26.13 |    100.00 \n",
      "----------------------+----------------------+----------\n",
      " Prefer not to answer |         5          0 |         5 \n",
      "                      |    100.00       0.00 |    100.00 \n",
      "----------------------+----------------------+----------\n",
      "                Total |       265         72 |       337 \n",
      "                      |     78.64      21.36 |    100.00 \n"
     ]
    }
   ],
   "source": [
    "tab gender early_adopt___1, col nokey\n",
    "tab gender early_adopt___3, col nokey\n",
    "tab gender early_adopt___4, col nokey\n",
    "\n",
    "tab gender earliest, col nokey\n",
    "\n",
    "tab gender early, col nokey\n",
    "tab gender early, row nokey"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<br>\n",
    "<font color='blue'>\n",
    "The male:female ratio was 2:1 among respondents, but proportionately more females (26%) than males (19%) were early adopters.\n",
    "    </font>"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "## Years in practice"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Among non-early prescribers:\n",
      "\n",
      "\n",
      "     Please indicate your total |\n",
      "    number of years in practice |\n",
      "      following completion of r |      Freq.\n",
      "--------------------------------+------------+---------------------------------\n",
      "                            < 5 |         30 |*************\n",
      "                          5 -15 |         55 |************************\n",
      "                        16 - 25 |         77 |*********************************\n",
      "                        26 - 35 |         59 |*************************\n",
      "                           > 35 |         44 |*******************\n",
      "--------------------------------+------------+---------------------------------\n",
      "                          Total |        265 \n",
      "\n",
      "Among early prescribers:\n",
      "\n",
      "\n",
      "     Please indicate your total |\n",
      "    number of years in practice |\n",
      "      following completion of r |      Freq.\n",
      "--------------------------------+------------+---------------------------------\n",
      "                            < 5 |         13 |*************\n",
      "                          5 -15 |         16 |****************\n",
      "                        16 - 25 |         12 |************\n",
      "                        26 - 35 |         13 |*************\n",
      "                           > 35 |         18 |******************\n",
      "--------------------------------+------------+---------------------------------\n",
      "                          Total |         72 \n",
      "\n",
      "\n",
      " Please indicate your |\n",
      "total number of years |     Enjoys novel\n",
      "in practice following |      prescribing\n",
      "      completion of r |         0          1 |     Total\n",
      "----------------------+----------------------+----------\n",
      "                  < 5 |        30         13 |        43 \n",
      "                      |     11.32      18.06 |     12.76 \n",
      "----------------------+----------------------+----------\n",
      "                5 -15 |        55         16 |        71 \n",
      "                      |     20.75      22.22 |     21.07 \n",
      "----------------------+----------------------+----------\n",
      "              16 - 25 |        77         12 |        89 \n",
      "                      |     29.06      16.67 |     26.41 \n",
      "----------------------+----------------------+----------\n",
      "              26 - 35 |        59         13 |        72 \n",
      "                      |     22.26      18.06 |     21.36 \n",
      "----------------------+----------------------+----------\n",
      "                 > 35 |        44         18 |        62 \n",
      "                      |     16.60      25.00 |     18.40 \n",
      "----------------------+----------------------+----------\n",
      "                Total |       265         72 |       337 \n",
      "                      |    100.00     100.00 |    100.00 \n",
      "\n",
      "\n",
      "Two-sample Wilcoxon rank-sum (Mann-Whitney) test\n",
      "\n",
      "       early |      obs    rank sum    expected\n",
      "-------------+---------------------------------\n",
      "           0 |      265     44864.5       44785\n",
      "           1 |       72     12088.5       12168\n",
      "-------------+---------------------------------\n",
      "    combined |      337       56953       56953\n",
      "\n",
      "unadjusted variance   537420.00\n",
      "adjustment for ties   -24624.36\n",
      "                     ----------\n",
      "adjusted variance     512795.64\n",
      "\n",
      "Ho: years_~c(early==0) = years_~c(early==1)\n",
      "             z =   0.111\n",
      "    Prob > |z| =   0.9116\n",
      "\n",
      "Note: Exact p-value is not computed by default for sample sizes > 200.\n",
      "      Use option exact to compute it.\n",
      "\n",
      "\n",
      " Please indicate your |\n",
      "total number of years | Self-identified early\n",
      "in practice following |       adopters\n",
      "      completion of r |         0          1 |     Total\n",
      "----------------------+----------------------+----------\n",
      "                  < 5 |        41          2 |        43 \n",
      "                      |     12.85      11.11 |     12.76 \n",
      "----------------------+----------------------+----------\n",
      "                5 -15 |        68          3 |        71 \n",
      "                      |     21.32      16.67 |     21.07 \n",
      "----------------------+----------------------+----------\n",
      "              16 - 25 |        88          1 |        89 \n",
      "                      |     27.59       5.56 |     26.41 \n",
      "----------------------+----------------------+----------\n",
      "              26 - 35 |        69          3 |        72 \n",
      "                      |     21.63      16.67 |     21.36 \n",
      "----------------------+----------------------+----------\n",
      "                 > 35 |        53          9 |        62 \n",
      "                      |     16.61      50.00 |     18.40 \n",
      "----------------------+----------------------+----------\n",
      "                Total |       319         18 |       337 \n",
      "                      |    100.00     100.00 |    100.00 \n",
      "\n",
      "\n",
      "Two-sample Wilcoxon rank-sum (Mann-Whitney) test\n",
      "\n",
      "    earliest |      obs    rank sum    expected\n",
      "-------------+---------------------------------\n",
      "           0 |      319       53036       53911\n",
      "           1 |       18        3917        3042\n",
      "-------------+---------------------------------\n",
      "    combined |      337       56953       56953\n",
      "\n",
      "unadjusted variance   161733.00\n",
      "adjustment for ties    -7410.54\n",
      "                     ----------\n",
      "adjusted variance     154322.46\n",
      "\n",
      "Ho: years_~c(earliest==0) = years_~c(earliest==1)\n",
      "             z =  -2.227\n",
      "    Prob > |z| =   0.0259\n",
      "\n",
      "Note: Exact p-value is not computed by default for sample sizes > 200.\n",
      "      Use option exact to compute it.\n"
     ]
    }
   ],
   "source": [
    "di \"Among non-early prescribers:\"\n",
    "tab years_prac if early==0, p \n",
    "di \"Among early prescribers:\"\n",
    "tab years_prac if early==1, p\n",
    "\n",
    "tab years_prac early, col nokey\n",
    "ranksum years_prac, by(early)\n",
    "tab years_prac earliest, col nokey\n",
    "ranksum years_prac, by(earliest)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "There is some murkiness here and low cell sizes, but the trend is worth keeping an eye on.\n",
    "<br>\n",
    "<font color='blue'>\n",
    "Early prescribers tended to be disproportionately in early or late career (<15 and 35+ practice-years, respectively).\n",
    "    </font>\n",
    "    <br>"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "## Number of patients"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "        On |\n",
      "  average, |\n",
      "across all |\n",
      "  practice |\n",
      "     sites |\n",
      "  (primary |\n",
      "  practice |\n",
      " and other |     Enjoys novel\n",
      " practice) |      prescribing\n",
      "       how |         0          1 |     Total\n",
      "-----------+----------------------+----------\n",
      "      < 25 |        33          5 |        38 \n",
      "           |     12.45       6.94 |     11.28 \n",
      "-----------+----------------------+----------\n",
      "     25-49 |        54         17 |        71 \n",
      "           |     20.38      23.61 |     21.07 \n",
      "-----------+----------------------+----------\n",
      "     50-74 |        69         18 |        87 \n",
      "           |     26.04      25.00 |     25.82 \n",
      "-----------+----------------------+----------\n",
      "    75-100 |        73         20 |        93 \n",
      "           |     27.55      27.78 |     27.60 \n",
      "-----------+----------------------+----------\n",
      "     > 100 |        36         12 |        48 \n",
      "           |     13.58      16.67 |     14.24 \n",
      "-----------+----------------------+----------\n",
      "     Total |       265         72 |       337 \n",
      "           |    100.00     100.00 |    100.00 \n"
     ]
    }
   ],
   "source": [
    "tab no_patients early, col nokey"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<font color='blue'>\n",
    "There was no difference in number of patients seen per week.</font>"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "## Specialty"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "         Which of the |\n",
      "       following best |     Enjoys novel\n",
      "       describes your |      prescribing\n",
      "  primary specialty?  |         0          1 |     Total\n",
      "----------------------+----------------------+----------\n",
      "   Addiction medicine |         2          4 |         6 \n",
      "                      |      0.75       5.56 |      1.78 \n",
      "----------------------+----------------------+----------\n",
      "       Anesthesiology |         6          0 |         6 \n",
      "                      |      2.26       0.00 |      1.78 \n",
      "----------------------+----------------------+----------\n",
      "Cardiovascular diseas |         3          1 |         4 \n",
      "                      |      1.13       1.39 |      1.19 \n",
      "----------------------+----------------------+----------\n",
      "Critical care medicin |         2          0 |         2 \n",
      "                      |      0.75       0.00 |      0.59 \n",
      "----------------------+----------------------+----------\n",
      "   Emergency medicine |        42          6 |        48 \n",
      "                      |     15.85       8.33 |     14.24 \n",
      "----------------------+----------------------+----------\n",
      "      Family medicine |        53         19 |        72 \n",
      "                      |     20.00      26.39 |     21.36 \n",
      "----------------------+----------------------+----------\n",
      "      General surgery |        18          2 |        20 \n",
      "                      |      6.79       2.78 |      5.93 \n",
      "----------------------+----------------------+----------\n",
      "Hematology & Oncology |         5          4 |         9 \n",
      "                      |      1.89       5.56 |      2.67 \n",
      "----------------------+----------------------+----------\n",
      "    Internal medicine |        40         11 |        51 \n",
      "                      |     15.09      15.28 |     15.13 \n",
      "----------------------+----------------------+----------\n",
      "Neurology or Neurolog |         2          0 |         2 \n",
      "                      |      0.75       0.00 |      0.59 \n",
      "----------------------+----------------------+----------\n",
      "Obstetrics & Gynecolo |        17          8 |        25 \n",
      "                      |      6.42      11.11 |      7.42 \n",
      "----------------------+----------------------+----------\n",
      "        Ophthalmology |         2          0 |         2 \n",
      "                      |      0.75       0.00 |      0.59 \n",
      "----------------------+----------------------+----------\n",
      "   Orthopedic surgery |        13          4 |        17 \n",
      "                      |      4.91       5.56 |      5.04 \n",
      "----------------------+----------------------+----------\n",
      "       Otolaryngology |         3          0 |         3 \n",
      "                      |      1.13       0.00 |      0.89 \n",
      "----------------------+----------------------+----------\n",
      "        Pain medicine |        10          2 |        12 \n",
      "                      |      3.77       2.78 |      3.56 \n",
      "----------------------+----------------------+----------\n",
      "Pediatrics or Neonata |         9          1 |        10 \n",
      "                      |      3.40       1.39 |      2.97 \n",
      "----------------------+----------------------+----------\n",
      "      Plastic surgery |         4          1 |         5 \n",
      "                      |      1.51       1.39 |      1.48 \n",
      "----------------------+----------------------+----------\n",
      "           Psychiatry |         2          2 |         4 \n",
      "                      |      0.75       2.78 |      1.19 \n",
      "----------------------+----------------------+----------\n",
      "              Urology |         3          2 |         5 \n",
      "                      |      1.13       2.78 |      1.48 \n",
      "----------------------+----------------------+----------\n",
      "                Other |        29          5 |        34 \n",
      "                      |     10.94       6.94 |     10.09 \n",
      "----------------------+----------------------+----------\n",
      "                Total |       265         72 |       337 \n",
      "                      |    100.00     100.00 |    100.00 \n"
     ]
    }
   ],
   "source": [
    "tab specialty_type early, col nokey"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<font color='blue'>\n",
    "There were no significant differences in medical specialty... possibly except emergency medicine and general surgery less likely, and hem/onc and OB/GYN more likely to be early adopters, but cell sizes were small.</font>"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "## Practice setting"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "         Which of the |\n",
      "       following best |\n",
      "   characterizes your |     Enjoys novel\n",
      "     primary practice |      prescribing\n",
      "             setting? |         0          1 |     Total\n",
      "----------------------+----------------------+----------\n",
      "        Solo practice |        28          9 |        37 \n",
      "                      |     10.61      12.50 |     11.01 \n",
      "----------------------+----------------------+----------\n",
      "Small private group p |        33          9 |        42 \n",
      "                      |     12.50      12.50 |     12.50 \n",
      "----------------------+----------------------+----------\n",
      "Large private group p |        32         14 |        46 \n",
      "                      |     12.12      19.44 |     13.69 \n",
      "----------------------+----------------------+----------\n",
      "    Academic practice |        36          9 |        45 \n",
      "                      |     13.64      12.50 |     13.39 \n",
      "----------------------+----------------------+----------\n",
      " Emergency department |        43          7 |        50 \n",
      "                      |     16.29       9.72 |     14.88 \n",
      "----------------------+----------------------+----------\n",
      "Hospital-based clinic |        48         13 |        61 \n",
      "                      |     18.18      18.06 |     18.15 \n",
      "----------------------+----------------------+----------\n",
      "   Hospital inpatient |        22          7 |        29 \n",
      "                      |      8.33       9.72 |      8.63 \n",
      "----------------------+----------------------+----------\n",
      "VA health-system or a |         8          0 |         8 \n",
      "                      |      3.03       0.00 |      2.38 \n",
      "----------------------+----------------------+----------\n",
      "                Other |        14          4 |        18 \n",
      "                      |      5.30       5.56 |      5.36 \n",
      "----------------------+----------------------+----------\n",
      "                Total |       264         72 |       336 \n",
      "                      |    100.00     100.00 |    100.00 \n"
     ]
    }
   ],
   "source": [
    "tab prac_type early, col nokey"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<font color='blue'>\n",
    "Likewise, there were no appreciable differences in practice setting, possibly with the exception of ED physicians less likely to prescribe new medicines.</font>"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "# Opioid Prescribing\n",
    "## Risk stratification"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "         Which of the |\n",
      "            following |\n",
      "  risk-stratification |     Enjoys novel\n",
      "    tools do you most |      prescribing\n",
      "   commonly utilize?  |         0          1 |     Total\n",
      "----------------------+----------------------+----------\n",
      "     Opioid risk tool |        27          7 |        34 \n",
      "                      |     10.15       8.43 |      9.74 \n",
      "----------------------+----------------------+----------\n",
      "Screener and Opioid A |         4          2 |         6 \n",
      "                      |      1.50       2.41 |      1.72 \n",
      "----------------------+----------------------+----------\n",
      "Screener and Opioid A |         7          6 |        13 \n",
      "                      |      2.63       7.23 |      3.72 \n",
      "----------------------+----------------------+----------\n",
      " Brief Risk Interview |        23         11 |        34 \n",
      "                      |      8.65      13.25 |      9.74 \n",
      "----------------------+----------------------+----------\n",
      "                Other |         3          1 |         4 \n",
      "                      |      1.13       1.20 |      1.15 \n",
      "----------------------+----------------------+----------\n",
      "                    . |       202         56 |       258 \n",
      "                      |     75.94      67.47 |     73.93 \n",
      "----------------------+----------------------+----------\n",
      "                Total |       266         83 |       349 \n",
      "                      |    100.00     100.00 |    100.00 \n",
      "\n",
      "\n",
      "(258 real changes made)\n",
      "\n",
      "                                                         Proportion\n",
      "                 |   Exposed   Unexposed  |      Total     Exposed\n",
      "-----------------+------------------------+------------------------\n",
      "           Cases |        27          64  |         91       0.2967\n",
      "        Controls |        56         202  |        258       0.2171\n",
      "-----------------+------------------------+------------------------\n",
      "           Total |        83         266  |        349       0.2378\n",
      "                 |                        |\n",
      "                 |      Point estimate    |    [95% Conf. Interval]\n",
      "                 |------------------------+------------------------\n",
      "      Odds ratio |         1.521763       |     .849372    2.684345 (exact)\n",
      " Attr. frac. ex. |         .3428676       |   -.1773405    .6274696 (exact)\n",
      " Attr. frac. pop |           .10173       |\n",
      "                 +-------------------------------------------------\n",
      "                               chi2(1) =     2.35  Pr>chi2 = 0.1249\n"
     ]
    }
   ],
   "source": [
    "tab riskstrat early, m col nokey\n",
    "    gen risktool = 1\n",
    "        replace risktool=0 if riskstrat==.\n",
    "            cc risktool early"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<font color='blue'>\n",
    "Early prescribers were more likely to use opioid risk stratification tools (32% vs. 24%). Early prescribers were more likely to use opioid risk stratification tools (OR 1.5; 0.85, 2.7). </font>\n",
    "\n",
    "---\n",
    "\n",
    "## ADFs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "   Any ADF |     Enjoys novel\n",
      "prescribin |      prescribing\n",
      "         g |         0          1 |     Total\n",
      "-----------+----------------------+----------\n",
      "         0 |       131         39 |       170 \n",
      "           |     49.25      46.99 |     48.71 \n",
      "-----------+----------------------+----------\n",
      "         1 |       135         44 |       179 \n",
      "           |     50.75      53.01 |     51.29 \n",
      "-----------+----------------------+----------\n",
      "     Total |       266         83 |       349 \n",
      "           |    100.00     100.00 |    100.00 \n",
      "\n",
      "                                                         Proportion\n",
      "                 |   Exposed   Unexposed  |      Total     Exposed\n",
      "-----------------+------------------------+------------------------\n",
      "           Cases |        44         135  |        179       0.2458\n",
      "        Controls |        39         131  |        170       0.2294\n",
      "-----------------+------------------------+------------------------\n",
      "           Total |        83         266  |        349       0.2378\n",
      "                 |                        |\n",
      "                 |      Point estimate    |    [95% Conf. Interval]\n",
      "                 |------------------------+------------------------\n",
      "      Odds ratio |         1.094777       |    .6488239    1.850668 (exact)\n",
      " Attr. frac. ex. |         .0865718       |   -.5412502    .4596547 (exact)\n",
      " Attr. frac. pop |         .0212802       |\n",
      "                 +-------------------------------------------------\n",
      "                               chi2(1) =     0.13  Pr>chi2 = 0.7191\n"
     ]
    }
   ],
   "source": [
    "tab anyadf early, col nokey\n",
    "cc anyadf early"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "       Any |\n",
      "non-OxyCon |\n",
      "   tin ADF |     Enjoys novel\n",
      "prescribin |      prescribing\n",
      "         g |         0          1 |     Total\n",
      "-----------+----------------------+----------\n",
      "         0 |       217         63 |       280 \n",
      "           |     81.58      75.90 |     80.23 \n",
      "-----------+----------------------+----------\n",
      "         1 |        49         20 |        69 \n",
      "           |     18.42      24.10 |     19.77 \n",
      "-----------+----------------------+----------\n",
      "     Total |       266         83 |       349 \n",
      "           |    100.00     100.00 |    100.00 \n",
      "\n",
      "                                                         Proportion\n",
      "                 |   Exposed   Unexposed  |      Total     Exposed\n",
      "-----------------+------------------------+------------------------\n",
      "           Cases |        20          49  |         69       0.2899\n",
      "        Controls |        63         217  |        280       0.2250\n",
      "-----------------+------------------------+------------------------\n",
      "           Total |        83         266  |        349       0.2378\n",
      "                 |                        |\n",
      "                 |      Point estimate    |    [95% Conf. Interval]\n",
      "                 |------------------------+------------------------\n",
      "      Odds ratio |         1.405896       |    .7344813    2.617604 (exact)\n",
      " Attr. frac. ex. |         .2887097       |    -.361505    .6179712 (exact)\n",
      " Attr. frac. pop |          .083684       |\n",
      "                 +-------------------------------------------------\n",
      "                               chi2(1) =     1.28  Pr>chi2 = 0.2570\n"
     ]
    }
   ],
   "source": [
    "tab anynotocadf early, col nokey\n",
    "cc anynotocadf early"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "## Innovation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 87,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "      Innovative |\n",
      "       nature of |     Enjoys novel\n",
      "abuse-deterrence |      prescribing\n",
      "      mechanisms |         0          1 |     Total\n",
      "-----------------+----------------------+----------\n",
      "    No influence |        12          1 |        13 \n",
      "                 |      4.51       1.20 |      3.72 \n",
      "-----------------+----------------------+----------\n",
      "Little influence |        32          1 |        33 \n",
      "                 |     12.03       1.20 |      9.46 \n",
      "-----------------+----------------------+----------\n",
      "  Some influence |        32         23 |        55 \n",
      "                 |     12.03      27.71 |     15.76 \n",
      "-----------------+----------------------+----------\n",
      " Great influence |         5          5 |        10 \n",
      "                 |      1.88       6.02 |      2.87 \n",
      "-----------------+----------------------+----------\n",
      "               . |       185         53 |       238 \n",
      "                 |     69.55      63.86 |     68.19 \n",
      "-----------------+----------------------+----------\n",
      "           Total |       266         83 |       349 \n",
      "                 |    100.00     100.00 |    100.00 \n",
      "\n",
      "\n",
      "Two-sample Wilcoxon rank-sum (Mann-Whitney) test\n",
      "\n",
      "       early |      obs    rank sum    expected\n",
      "-------------+---------------------------------\n",
      "           0 |       81      3944.5        4536\n",
      "           1 |       30      2271.5        1680\n",
      "-------------+---------------------------------\n",
      "    combined |      111        6216        6216\n",
      "\n",
      "unadjusted variance    22680.00\n",
      "adjustment for ties    -3406.48\n",
      "                     ----------\n",
      "adjusted variance      19273.52\n",
      "\n",
      "Ho: innovate(early==0) = innovate(early==1)\n",
      "             z =  -4.261\n",
      "    Prob > |z| =   0.0000\n",
      "    Exact Prob =   0.0000\n",
      "\n",
      "\n",
      "           |     Enjoys novel\n",
      "innovinflu |      prescribing\n",
      "      ence |         0          1 |     Total\n",
      "-----------+----------------------+----------\n",
      "         0 |        44          2 |        46 \n",
      "           |     54.32       6.67 |     41.44 \n",
      "-----------+----------------------+----------\n",
      "         1 |        37         28 |        65 \n",
      "           |     45.68      93.33 |     58.56 \n",
      "-----------+----------------------+----------\n",
      "     Total |        81         30 |       111 \n",
      "           |    100.00     100.00 |    100.00 \n"
     ]
    }
   ],
   "source": [
    "tab innovate early, m col nokey\n",
    "    ranksum innovate if innovate!=., by(early)\n",
    "tab innovinfluence early, col nokey"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<font color='blue'>\n",
    "Early and standard prescribers had similar abuse deterrent formulation (ADF) opioid prescribing (OR 1.1; 0.6, 1.8). However, early adopters were more likely (OR 1.4; 0.7, 2.6) to prescribe newer non-OxyContin ADFs, with 93% endorsing \"innovative nature of abuse-deterrence mechanisms\" as a consideration.</font>\n",
    "<br>\n",
    "<br>\n",
    "\n",
    "---\n",
    "\n",
    "## Legislation, PMP, limits"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 88,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "   At this |\n",
      "     time, |\n",
      " would you |\n",
      "   support |\n",
      "     state |\n",
      "legislatio |\n",
      "         n |\n",
      " mandating |     Enjoys novel\n",
      "third-part |      prescribing\n",
      "y payer co |         0          1 |     Total\n",
      "-----------+----------------------+----------\n",
      "        No |        78          8 |        86 \n",
      "           |     30.23      10.96 |     25.98 \n",
      "-----------+----------------------+----------\n",
      "       Yes |       180         65 |       245 \n",
      "           |     69.77      89.04 |     74.02 \n",
      "-----------+----------------------+----------\n",
      "     Total |       258         73 |       331 \n",
      "           |    100.00     100.00 |    100.00 \n",
      "\n",
      "\n",
      "    Variable    |     Missing          Total     Percent Missing\n",
      "----------------+-----------------------------------------------\n",
      "    state_legis |          18            349           5.16\n",
      "----------------+-----------------------------------------------\n",
      "\n",
      "                                                         Proportion\n",
      "                 |   Exposed   Unexposed  |      Total     Exposed\n",
      "-----------------+------------------------+------------------------\n",
      "           Cases |        65         180  |        245       0.2653\n",
      "        Controls |         8          78  |         86       0.0930\n",
      "-----------------+------------------------+------------------------\n",
      "           Total |        73         258  |        331       0.2205\n",
      "                 |                        |\n",
      "                 |      Point estimate    |    [95% Conf. Interval]\n",
      "                 |------------------------+------------------------\n",
      "      Odds ratio |         3.520833       |    1.579104    8.879399 (exact)\n",
      " Attr. frac. ex. |         .7159763       |    .3667297    .8873798 (exact)\n",
      " Attr. frac. pop |         .1899529       |\n",
      "                 +-------------------------------------------------\n",
      "                               chi2(1) =    10.99  Pr>chi2 = 0.0009\n"
     ]
    }
   ],
   "source": [
    "tab state_legis early, col nokey\n",
    "mdesc state_legis\n",
    "cc state_legis early"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "                     |     Enjoys novel\n",
      "   Prescribing (days |      prescribing\n",
      "      supply) limits |         0          1 |     Total\n",
      "---------------------+----------------------+----------\n",
      "Not effective at all |        18          9 |        27 \n",
      "                     |      6.77      10.84 |      7.74 \n",
      "---------------------+----------------------+----------\n",
      "  Somewhat effective |        81         18 |        99 \n",
      "                     |     30.45      21.69 |     28.37 \n",
      "---------------------+----------------------+----------\n",
      "           Effective |        99         26 |       125 \n",
      "                     |     37.22      31.33 |     35.82 \n",
      "---------------------+----------------------+----------\n",
      "      Very effective |        59         14 |        73 \n",
      "                     |     22.18      16.87 |     20.92 \n",
      "---------------------+----------------------+----------\n",
      "              Unsure |         9          4 |        13 \n",
      "                     |      3.38       4.82 |      3.72 \n",
      "---------------------+----------------------+----------\n",
      "                   . |         0         12 |        12 \n",
      "                     |      0.00      14.46 |      3.44 \n",
      "---------------------+----------------------+----------\n",
      "               Total |       266         83 |       349 \n",
      "                     |    100.00     100.00 |    100.00 \n",
      "\n",
      "\n",
      "Two-sample Wilcoxon rank-sum (Mann-Whitney) test\n",
      "\n",
      "       early |      obs    rank sum    expected\n",
      "-------------+---------------------------------\n",
      "           0 |      257       42192     41762.5\n",
      "           1 |       67       10458     10887.5\n",
      "-------------+---------------------------------\n",
      "    combined |      324       52650       52650\n",
      "\n",
      "unadjusted variance   466347.92\n",
      "adjustment for ties   -45683.36\n",
      "                     ----------\n",
      "adjusted variance     420664.55\n",
      "\n",
      "Ho: dslimits(early==0) = dslimits(early==1)\n",
      "             z =   0.662\n",
      "    Prob > |z| =   0.5078\n",
      "\n",
      "Note: Exact p-value is not computed by default for sample sizes > 200.\n",
      "      Use option exact to compute it.\n"
     ]
    }
   ],
   "source": [
    "tab dslimits early, col nokey m\n",
    "    ranksum dslimits if dslimits!=5, by(early)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "                     |     Enjoys novel\n",
      "                     |      prescribing\n",
      "Urine drug screening |         0          1 |     Total\n",
      "---------------------+----------------------+----------\n",
      "Not effective at all |        22          4 |        26 \n",
      "                     |      8.27       4.82 |      7.45 \n",
      "---------------------+----------------------+----------\n",
      "  Somewhat effective |        89         24 |       113 \n",
      "                     |     33.46      28.92 |     32.38 \n",
      "---------------------+----------------------+----------\n",
      "           Effective |        99         15 |       114 \n",
      "                     |     37.22      18.07 |     32.66 \n",
      "---------------------+----------------------+----------\n",
      "      Very effective |        42         23 |        65 \n",
      "                     |     15.79      27.71 |     18.62 \n",
      "---------------------+----------------------+----------\n",
      "              Unsure |        14          6 |        20 \n",
      "                     |      5.26       7.23 |      5.73 \n",
      "---------------------+----------------------+----------\n",
      "                   . |         0         11 |        11 \n",
      "                     |      0.00      13.25 |      3.15 \n",
      "---------------------+----------------------+----------\n",
      "               Total |       266         83 |       349 \n",
      "                     |    100.00     100.00 |    100.00 \n",
      "\n",
      "\n",
      "Two-sample Wilcoxon rank-sum (Mann-Whitney) test\n",
      "\n",
      "       early |      obs    rank sum    expected\n",
      "-------------+---------------------------------\n",
      "           0 |      252     39149.5       40194\n",
      "           1 |       66     11571.5       10527\n",
      "-------------+---------------------------------\n",
      "    combined |      318       50721       50721\n",
      "\n",
      "unadjusted variance   442134.00\n",
      "adjustment for ties   -44221.82\n",
      "                     ----------\n",
      "adjusted variance     397912.18\n",
      "\n",
      "Ho: urineds(early==0) = urineds(early==1)\n",
      "             z =  -1.656\n",
      "    Prob > |z| =   0.0978\n",
      "\n",
      "Note: Exact p-value is not computed by default for sample sizes > 200.\n",
      "      Use option exact to compute it.\n"
     ]
    }
   ],
   "source": [
    "tab urineds early, col nokey m\n",
    "    ranksum urineds if urineds!=5, by(early)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "        Checking the |\n",
      "   prescription drug |     Enjoys novel\n",
      "  monitoring program |      prescribing\n",
      "            (KASPER) |         0          1 |     Total\n",
      "---------------------+----------------------+----------\n",
      "Not effective at all |         6          0 |         6 \n",
      "                     |      2.26       0.00 |      1.72 \n",
      "---------------------+----------------------+----------\n",
      "  Somewhat effective |        65         12 |        77 \n",
      "                     |     24.44      14.46 |     22.06 \n",
      "---------------------+----------------------+----------\n",
      "           Effective |        91         27 |       118 \n",
      "                     |     34.21      32.53 |     33.81 \n",
      "---------------------+----------------------+----------\n",
      "      Very effective |       100         31 |       131 \n",
      "                     |     37.59      37.35 |     37.54 \n",
      "---------------------+----------------------+----------\n",
      "              Unsure |         4          1 |         5 \n",
      "                     |      1.50       1.20 |      1.43 \n",
      "---------------------+----------------------+----------\n",
      "                   . |         0         12 |        12 \n",
      "                     |      0.00      14.46 |      3.44 \n",
      "---------------------+----------------------+----------\n",
      "               Total |       266         83 |       349 \n",
      "                     |    100.00     100.00 |    100.00 \n",
      "\n",
      "\n",
      "Two-sample Wilcoxon rank-sum (Mann-Whitney) test\n",
      "\n",
      "       early |      obs    rank sum    expected\n",
      "-------------+---------------------------------\n",
      "           0 |      262     42613.5       43623\n",
      "           1 |       70     12664.5       11655\n",
      "-------------+---------------------------------\n",
      "    combined |      332       55278       55278\n",
      "\n",
      "unadjusted variance   508935.00\n",
      "adjustment for ties   -60463.82\n",
      "                     ----------\n",
      "adjusted variance     448471.18\n",
      "\n",
      "Ho: kasper(early==0) = kasper(early==1)\n",
      "             z =  -1.507\n",
      "    Prob > |z| =   0.1317\n",
      "\n",
      "Note: Exact p-value is not computed by default for sample sizes > 200.\n",
      "      Use option exact to compute it.\n"
     ]
    }
   ],
   "source": [
    "tab kasper early, col nokey m\n",
    "    ranksum kasper if kasper!=5, by(early)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "<font color='blue'>\n",
    "They were more likely to support legislation mandating insurance coverage for ADFs (OR 1.3), and more strongly endorsed technical solutions like electronic prescription monitoring programs and urine drug screens, while more vehemently opposing prescribing limits. </font>"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "---\n",
    "# Survey completion sub-analysis\n",
    "Objective: To assess furthest question responded to as a marker for inclusion. This was deemed important because some respondents clicked on no more than the initial screen."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "/Users/nabarun/Dropbox/Projects/P1 Surveys\n",
      "\n",
      "\n",
      "\n",
      "(MethodologicalAdvanc_DATA_NOHDRS_2020-01-28_1510.csv)\n",
      "\n",
      "Exclude non-controlled substance prescribers and incomplete surveys:\n",
      "\n",
      "(206 observations deleted)\n",
      "\n",
      "\n",
      "           |        Observations\n",
      "           |      total   distinct\n",
      "-----------+----------------------\n",
      " record_id |        480        480\n",
      "\n",
      "Check within early adopters:\n",
      "\n",
      "\n",
      "\n",
      "(83 real changes made)\n",
      "\n",
      "\n",
      "     Enjoys |\n",
      "      novel |\n",
      "prescribing |      Freq.     Percent        Cum.\n",
      "------------+-----------------------------------\n",
      "          0 |        397       82.71       82.71\n",
      "          1 |         83       17.29      100.00\n",
      "------------+-----------------------------------\n",
      "      Total |        480      100.00\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Drop free text strings:\n",
      "\n",
      "\n",
      "(note: j = 5 6 7 8 9 10 11 14 15 16 17 18 19 20 22 23 24 25 26 27 28 29 30 31 32 34 35 36 \n",
      "> 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 64 66 67 6\n",
      "> 8 69 70 71 72 74 75 76 77 78 79 80 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 99 100 1\n",
      "> 02 103 105)\n",
      "\n",
      "Data                               wide   ->   long\n",
      "-----------------------------------------------------------------------------\n",
      "Number of obs.                      480   ->   42720\n",
      "Number of variables                  92   ->       5\n",
      "j variable (89 values)                    ->   _j\n",
      "xij variables:\n",
      "                         v5 v6 ... v105   ->   v\n",
      "-----------------------------------------------------------------------------\n",
      "\n",
      "(16,405 observations deleted)\n",
      "\n",
      "(17,325 observations deleted)\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "Duplicates in terms of all variables\n",
      "\n",
      "(8,566 observations deleted)\n",
      "\n",
      "Describe length of completeness among incomplete surveys:\n",
      "\n",
      "\n",
      "       last |      Freq.     Percent        Cum.\n",
      "------------+-----------------------------------\n",
      "          5 |         35       40.70       40.70\n",
      "          6 |          1        1.16       41.86\n",
      "         10 |          2        2.33       44.19\n",
      "         11 |         21       24.42       68.60\n",
      "         30 |          3        3.49       72.09\n",
      "         31 |          5        5.81       77.91\n",
      "         32 |          4        4.65       82.56\n",
      "         42 |          3        3.49       86.05\n",
      "         47 |          2        2.33       88.37\n",
      "         48 |          4        4.65       93.02\n",
      "         50 |          1        1.16       94.19\n",
      "         57 |          2        2.33       96.51\n",
      "         78 |          1        1.16       97.67\n",
      "         86 |          1        1.16       98.84\n",
      "         92 |          1        1.16      100.00\n",
      "------------+-----------------------------------\n",
      "      Total |         86      100.00\n",
      "\n",
      "Look at distribution within early prescribers:\n",
      "\n",
      "\n",
      "       last |      Freq.     Percent        Cum.\n",
      "------------+-----------------------------------\n",
      "         10 |          2       18.18       18.18\n",
      "         11 |          3       27.27       45.45\n",
      "         31 |          1        9.09       54.55\n",
      "         32 |          1        9.09       63.64\n",
      "         42 |          2       18.18       81.82\n",
      "         48 |          1        9.09       90.91\n",
      "         78 |          1        9.09      100.00\n",
      "------------+-----------------------------------\n",
      "      Total |         11      100.00\n"
     ]
    }
   ],
   "source": [
    "// Early adopter analysis for IPCE abstract\n",
    "//\n",
    "\n",
    "cd \"/Users/nabarun/Dropbox/Projects/P1 Surveys\"\n",
    "clear all\n",
    "set more off\n",
    "\n",
    "use prescriberky\n",
    "\n",
    "di \"Exclude non-controlled substance prescribers and incomplete surveys:\"\n",
    "keep if contr_sub==1\n",
    "distinct record_id\n",
    "\n",
    "di \"Check within early adopters:\"\n",
    "gen early=0\n",
    "    la var early \"Enjoys novel prescribing\"\n",
    "        replace early = 1 if early_adopt___1==1 | early_adopt___3==1 | early_adopt___4==1\n",
    "            tab early\n",
    "\n",
    "foreach x of varlist _all {\n",
    "rename `x' zz`x'\n",
    "} \n",
    "rename zz* v#, renumber\n",
    "    rename v1 id\n",
    "        rename v106 early\n",
    "            gen incomplete=regexm(lower(v3),\"not completed\")\n",
    "                di \"Drop free text strings:\"\"\n",
    "                    drop v2 v4 v3 v12 v13 v21 v33 v63 v65 v73 v81 v82 v98 v101 v104\n",
    "\n",
    "reshape long v, i(id)\n",
    "    drop if v==. & _j!=2\n",
    "        drop if inlist(v,0,1,2)\n",
    "\n",
    "bysort id: egen last = max(_j) \n",
    "    drop _j v \n",
    "\n",
    "duplicates drop\n",
    "\n",
    "di \"Describe length of completeness among incomplete surveys:\"\n",
    "tab last if incomplete==1\n",
    "\n",
    "di \"Look at distribution within early prescribers:\"\n",
    "tab last if incomplete==1 & early==1\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Interpretation\n",
    "About 70% of incomplete surveys respondents stopped after about the 11th question, which was the radio button question about familiarity with  ADF formulations and route of preventing abuse. This suggests a general unwillingness to engage in the route of exposure question, despite this being a key element of labeling.<br>\n",
    "<br>\n",
    "The analytic implication is to not limit by overall incomplete surveys, but rather to limit to those who we have a determiniation of early adopter status. Incomplete responses to specific later survey questions are to be treated as missing. Among early prescribers, there doesn't appear to be much of a pattern...5 or so did not complete beyond the familiarity/route table. Since the early adopter question construction relies on negative data (e.g., boxes unchecked, the handling of missingness can be differential to reflect the variable construction definition.<br>\n",
    "<br>\n",
    "The analysis above has been updated to refelct this design decision. There are 2 final exclusion criteria:<br><br> First, if limiting to controlled substance prescribers, removing 206 observations out of the original 686 responses received:\n",
    "`keep if contr_sub==1`\n",
    "<br><br>\n",
    "Second, remove incomplete surveys but retain surveys among early prescribers, removing 131 observations for an analysis set of 349.<br>\n",
    "`keep if physician_survey_complete==2 | early==1`\n",
    "<br><br>\n",
    "In the next iteration of the survey we should think about moving that radio button table or simplifying it.<br><br>\n",
    "\n",
    "---\n",
    "# Future considerations\n",
    "Replication in other states will be helpful to have more sample size. Further characterization of early adopters could require more or better questions. Using the `earliest` self-identified category could serve as a sub-group analysis for a specificity and strength gradient. I wonder if there are measures of sociality (professional connectedness) that might explain some of the tendency to prescribe early, e.g., network effect for incoming information about new drugs or social milleu where having conversations about new drugs is rewarding.\n",
    "\n",
    "---\n",
    "*fin.*"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Stata",
   "language": "stata",
   "name": "stata"
  },
  "language_info": {
   "codemirror_mode": "stata",
   "file_extension": ".do",
   "mimetype": "text/x-stata",
   "name": "stata",
   "version": "15.1"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
